Redmond Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $206K | Sell |
8,562
-2,008
| -19% | -$52.5K | 0.05% | 197 |
|
|
2026
Q1 | $297K | Buy |
10,570
+1,281
| +14% | +$34.1K | 0.08% | 178 |
|
|
2025
Q4 | $231K | Sell |
9,289
-1,999
| -18% | -$50.4K | 0.06% | 188 |
|
|
2025
Q3 | $288K | Sell |
11,288
-4,983
| -31% | -$123K | 0.07% | 186 |
|
|
2025
Q2 | $394K | Sell |
16,271
-1,779
| -10% | -$41.5K | 0.09% | 165 |
|
|
2025
Q1 | $457K | Sell |
18,050
-33
| -0.2% | -$864 | 0.12% | 152 |
|
|
2024
Q4 | $480K | Buy |
+18,083
| New | +$490K | 0.12% | 150 |
|
|
2023
Q1 | – | Sell |
-4,398
| Closed | -$225K | – | 170 |
|
|
2022
Q4 | $225K | Buy |
+4,398
| New | +$211K | 0.08% | 159 |
|
|
2022
Q3 | – | Sell |
-4,310
| Closed | -$226K | – | 179 |
|
|
2022
Q2 | $226K | Sell |
4,310
-26,258
| -86% | -$1.34M | 0.08% | 171 |
|
|
2022
Q1 | $1.58M | Sell |
30,568
-3,380
| -10% | -$175K | 0.47% | 75 |
|
|
2021
Q4 | $2M | Buy |
33,948
+3,831
| +13% | +$190K | 0.56% | 61 |
|
|
2021
Q3 | $1.29M | Buy |
30,117
+3
| +0% | +$133 | 0.41% | 78 |
|
|
2021
Q2 | $1.18M | Buy |
30,114
+174
| +0.6% | +$6.77K | 0.35% | 97 |
|
|
2021
Q1 | $1.08M | Buy |
29,940
+904
| +3% | +$32.1K | 0.34% | 99 |
|
|
2020
Q4 | $1.07M | Sell |
29,036
-1,832
| -6% | -$67.2K | 0.38% | 90 |
|
|
2020
Q3 | $1.07M | Buy |
30,868
+6,595
| +27% | +$231K | 0.45% | 75 |
|
|
2020
Q2 | $753K | Sell |
24,273
-87
| -0.4% | -$2.96K | 0.31% | 98 |
|
|
2020
Q1 | $754K | Buy |
24,360
+1,328
| +6% | +$45.3K | 0.38% | 81 |
|
|
2019
Q4 | $856K | Buy |
23,032
+2,976
| +15% | +$106K | 0.36% | 87 |
|
|
2019
Q3 | $684K | Buy |
20,056
+5,520
| +38% | +$201K | 0.3% | 101 |
|
|
2019
Q2 | $597K | Buy |
14,536
+233
| +2% | +$9.25K | 0.26% | 113 |
|
|
2019
Q1 | $576K | Buy |
14,303
+348
| +2% | +$13.9K | 0.25% | 116 |
|
|
2018
Q4 | $578K | Buy |
13,955
+102
| +0.7% | +$4.23K | 0.28% | 98 |
|
|
2018
Q3 | $579K | Buy |
13,853
+1
| +0% | +$38 | 0.23% | 118 |
|
|
2018
Q2 | $477K | Buy |
13,852
+1,212
| +10% | +$41.4K | 0.2% | 119 |
|
|
2018
Q1 | $426K | Sell |
12,640
-397
| -3% | -$13.6K | 0.19% | 122 |
|
|
2017
Q4 | $448K | Buy |
13,037
+601
| +5% | +$20.5K | 0.19% | 126 |
|
|
2017
Q3 | $421K | Sell |
12,436
-811
| -6% | -$26.1K | 0.19% | 126 |
|
|
2017
Q2 | $422K | Buy |
13,247
+331
| +3% | +$10.4K | 0.2% | 126 |
|
|
2017
Q1 | $419K | Hold |
12,916
| – | – | 0.21% | 119 |
|
|
2016
Q4 | $398K | Buy |
+12,916
| New | +$394K | 0.18% | 133 |
|
|
2013
Q3 | – | Sell |
-16,325
| Closed | -$434K | – | 150 |
|
|
2013
Q2 | $434K | Buy |
+16,325
| New | +$451K | 0.32% | 79 |
|
Other funds holding PFE
Redmond Asset Management's PFE Position: Q2 2026 in Review
Redmond Asset Management reduced its Pfizer (PFE) stake by 19% in Q2 2026, selling an estimated $52.5K and leaving 8,562 shares worth $206K. The position accounts for 0.05% of the portfolio, ranked #197.
Redmond Asset Management first reported a position in PFE in Q2 2013 and has held it in 32 quarters since. The position peaked at $2M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Redmond Asset Management held 8,562 shares of Pfizer worth $206K as of Q2 2026.
- Redmond Asset Management sold 2,008 Pfizer shares in Q2 2026, an estimated $52.5K.
- Pfizer made up 0.05% of Redmond Asset Management's portfolio in Q2 2026, its #197 holding.
- Redmond Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 32 quarters since.
- Redmond Asset Management's Pfizer position peaked at $2M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Redmond Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.